Strategy for Aortic Surgery Hemostasis

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT03917862

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03917862
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03917862. Randomized; no masking; primary purpose treatment. Start 2018-12-04 (actual); primary completion 2020-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Strategy for Aortic Surgery Hemostasis
Acronym
SASH
Condition
Ascending Aorta Abnormality
Condition
Ascending Aortic Dissection
Condition
Ascending Aorta Aneurysm
Intervention (Combination product)
TDM-621
Lead sponsor
University of Sao Paulo General Hospital (class: other)
Collaborator
3-D Matrix UK Ltd. (class: industry)
Collaborator
InCor Heart Institute (class: other)

Record details

Record id
cardio:ct-nct03917862
Content hash
ef0dad00be7849fbe3bb0ad88604954ccdb30ee8afb24cdba816dc9be5bb82dc